The mechanisms of action of vaccines containing aluminum adjuvants: an in vitro vs in vivo paradigm.
about
The Immunomodulatory Role of Adjuvants in Vaccines Formulated with the Recombinant Antigens Ov-103 and Ov-RAL-2 against Onchocerca volvulus in MiceInnate immune responses induced by the saponin adjuvant Matrix-M in specific pathogen free pigs.Virus-Like Particle (VLP) Plus Microcrystalline Tyrosine (MCT) Adjuvants Enhance Vaccine Efficacy Improving T and B Cell Immunogenicity and Protection against Plasmodium berghei/vivax.Insight into the cellular fate and toxicity of aluminium adjuvants used in clinically approved human vaccinations.Delta inulin-derived adjuvants that elicit Th1 phenotype following vaccination reduces respiratory syncytial virus lung titers without a reduction in lung immunopathology.Dose site reactions and related findings after vaccine administration in safety studies.Porcine Dendritic Cells as an In Vitro Model to Assess the Immunological Behaviour of Streptococcus suis Subunit Vaccine Formulations and the Polarizing Effect of Adjuvants.Rational incorporation of molecular adjuvants into a hybrid nanoparticle-based nicotine vaccine for immunotherapy against nicotine addiction.Sequestering of damage-associated molecular patterns (DAMPs): a possible mechanism affecting the immune-stimulating properties of aluminium adjuvants.Modeling for influenza vaccines and adjuvants profile for safety prediction system using gene expression profiling and statistical tools.ICP-MS determination of serum aluminum in monkeys subcutaneously administered an alhydrogel-formulated drug candidate.Safety and biodistribution of sulfated archaeal glycolipid archaeosomes as vaccine adjuvants.Vaccine antigens modulate the innate response of monocytes to Al(OH)3.Adjuvanted influenza vaccinesMolecular Signature of Aluminum Hydroxide Adjuvant in Ovine PBMCs by Integrated mRNA and microRNA Transcriptome SequencingThe allergic response mediated by fire ant venom proteinsUnraveling the enigma: elucidating the relationship between the physicochemical properties of aluminium-based adjuvants and their immunological mechanisms of action
P2860
Q28552440-53B52642-FD7A-45D2-96B7-C2A9B63FE260Q33717300-05F14401-192E-45B1-963F-444EDE35E50EQ33855899-87EEC4E0-C4B4-45FA-9F02-4D4CDCEFE867Q37168990-5304520D-D301-4292-9EB2-976EB17BB843Q37197103-650AAAE6-99C8-4D1A-B10D-8BB32FBB3725Q38770307-A1817A7F-7EA8-45ED-B713-A3479BEFA6B4Q40284594-66C008C7-2151-490C-9B7B-C014EC65E35EQ45074067-C7B842BD-D26C-4FF6-BB43-76DF3E846710Q47123344-BBE8AD8B-1FBF-42E6-8D15-286B6BCE5B3BQ48097634-A773CD34-7272-48E7-BA16-6108EE0F792EQ49679453-7BF9C8FC-10F0-482E-AED3-88DA290F42F0Q52394368-FD50B286-4A90-45DC-ADE1-D0F8486FAE45Q55230364-6F77094D-6BDB-45B7-8E29-473EEFB1B711Q57094841-768AB6A3-03A0-4CB9-9CF5-900D4058617EQ58572707-8C144BC0-3D45-41EC-AD56-114E600904E2Q58695426-5EF758FB-3AAC-4920-8473-17249A305E09Q59137099-0361C020-CC94-4C02-A38B-AF5B1642A21C
P2860
The mechanisms of action of vaccines containing aluminum adjuvants: an in vitro vs in vivo paradigm.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
The mechanisms of action of va ...... in vitro vs in vivo paradigm.
@en
type
label
The mechanisms of action of va ...... in vitro vs in vivo paradigm.
@en
prefLabel
The mechanisms of action of va ...... in vitro vs in vivo paradigm.
@en
P2860
P1433
P1476
The mechanisms of action of va ...... n in vitro vs in vivo paradigm
@en
P2093
Tirth Raj Ghimire
P2860
P2888
P356
10.1186/S40064-015-0972-0
P577
2015-04-16T00:00:00Z
P5875
P6179
1028134872